Cargando…

Prevalence and risk factors for retropharyngeal and retro-styloid lymph node metastasis in hypopharyngeal carcinoma

BACKGROUND: We evaluated the prevalence and identified the risk factors for retropharyngeal and retro-styloid lymph node metastasis (LNM) in patients with hypopharyngeal carcinoma (HPC). This was achieved using a combination of magnetic resonance (MR) and [(18) F]-fluoro-2-deoxy-D-glucose (FDG)–posi...

Descripción completa

Detalles Bibliográficos
Autores principales: Toya, Ryo, Matsuyama, Tomohiko, Saito, Tetsuo, Fukugawa, Yoshiyuki, Watakabe, Takahiro, Shiraishi, Shinya, Murakami, Daizo, Orita, Yorihisa, Hirai, Toshinori, Oya, Natsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422770/
https://www.ncbi.nlm.nih.gov/pubmed/37568173
http://dx.doi.org/10.1186/s13014-023-02322-4
_version_ 1785089294210170880
author Toya, Ryo
Matsuyama, Tomohiko
Saito, Tetsuo
Fukugawa, Yoshiyuki
Watakabe, Takahiro
Shiraishi, Shinya
Murakami, Daizo
Orita, Yorihisa
Hirai, Toshinori
Oya, Natsuo
author_facet Toya, Ryo
Matsuyama, Tomohiko
Saito, Tetsuo
Fukugawa, Yoshiyuki
Watakabe, Takahiro
Shiraishi, Shinya
Murakami, Daizo
Orita, Yorihisa
Hirai, Toshinori
Oya, Natsuo
author_sort Toya, Ryo
collection PubMed
description BACKGROUND: We evaluated the prevalence and identified the risk factors for retropharyngeal and retro-styloid lymph node metastasis (LNM) in patients with hypopharyngeal carcinoma (HPC). This was achieved using a combination of magnetic resonance (MR) and [(18) F]-fluoro-2-deoxy-D-glucose (FDG)–positron emission tomography (PET)/computed tomography (CT) images. METHODS: Two board-certified radiation oncologists retrospectively reviewed pretreatment FDG–PET/CT images and contrast-enhanced thin-slice CT and MR images of 155 patients with HPC who underwent radiotherapy. Fisher’s exact tests and logistic regression analyses were performed to assess the risk factors for LNM. RESULTS: Retropharyngeal LNM (RPLNM) was confirmed in 20 (13%) patients. Posterior wall (PW) tumors (odds ratio [OR]: 4.128, 95% confidence interval [CI]: 1.339–12.727; p = 0.014) and bilateral or contralateral cervical LNM (OR: 11.577, 95% CI: 2.135–62.789; p = 0.005) were significantly correlated with RPLNM. The RPLNM was found in 9 (32%) of the 28 patients with PW tumors. Of these 9 patients, 2 (7%) had ipsilateral RPLNM, 3 (11%) had contralateral RPLNM, and 4 (14%) had bilateral RPLNM. The PW tumors were significantly associated with contralateral RPLNM (p < 0.001). Retro-styloid LNM (RSLNM) was confirmed in two (1%) patients, both of whom had ipsilateral RSLNM with lymph nodes (LNs) of ≥ 15 mm in the upper limit of ipsilateral level II. A significant association was found between LNs of ≥ 15 mm in the upper limit of ipsilateral level II and ipsilateral RSLNM (p = 0.001). CONCLUSIONS: The RPLNM was identified in 13% of patients with HPC. The PW tumors and bilateral or contralateral cervical LNM were risk factors for RPLNM; particularly, PW tumors were a specific risk factor for contralateral RPLNM. Although the RSLNM was rare, LNs of ≥ 15 mm in the upper limit of ipsilateral level II were a risk factor for ipsilateral RSLNM.
format Online
Article
Text
id pubmed-10422770
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104227702023-08-13 Prevalence and risk factors for retropharyngeal and retro-styloid lymph node metastasis in hypopharyngeal carcinoma Toya, Ryo Matsuyama, Tomohiko Saito, Tetsuo Fukugawa, Yoshiyuki Watakabe, Takahiro Shiraishi, Shinya Murakami, Daizo Orita, Yorihisa Hirai, Toshinori Oya, Natsuo Radiat Oncol Research BACKGROUND: We evaluated the prevalence and identified the risk factors for retropharyngeal and retro-styloid lymph node metastasis (LNM) in patients with hypopharyngeal carcinoma (HPC). This was achieved using a combination of magnetic resonance (MR) and [(18) F]-fluoro-2-deoxy-D-glucose (FDG)–positron emission tomography (PET)/computed tomography (CT) images. METHODS: Two board-certified radiation oncologists retrospectively reviewed pretreatment FDG–PET/CT images and contrast-enhanced thin-slice CT and MR images of 155 patients with HPC who underwent radiotherapy. Fisher’s exact tests and logistic regression analyses were performed to assess the risk factors for LNM. RESULTS: Retropharyngeal LNM (RPLNM) was confirmed in 20 (13%) patients. Posterior wall (PW) tumors (odds ratio [OR]: 4.128, 95% confidence interval [CI]: 1.339–12.727; p = 0.014) and bilateral or contralateral cervical LNM (OR: 11.577, 95% CI: 2.135–62.789; p = 0.005) were significantly correlated with RPLNM. The RPLNM was found in 9 (32%) of the 28 patients with PW tumors. Of these 9 patients, 2 (7%) had ipsilateral RPLNM, 3 (11%) had contralateral RPLNM, and 4 (14%) had bilateral RPLNM. The PW tumors were significantly associated with contralateral RPLNM (p < 0.001). Retro-styloid LNM (RSLNM) was confirmed in two (1%) patients, both of whom had ipsilateral RSLNM with lymph nodes (LNs) of ≥ 15 mm in the upper limit of ipsilateral level II. A significant association was found between LNs of ≥ 15 mm in the upper limit of ipsilateral level II and ipsilateral RSLNM (p = 0.001). CONCLUSIONS: The RPLNM was identified in 13% of patients with HPC. The PW tumors and bilateral or contralateral cervical LNM were risk factors for RPLNM; particularly, PW tumors were a specific risk factor for contralateral RPLNM. Although the RSLNM was rare, LNs of ≥ 15 mm in the upper limit of ipsilateral level II were a risk factor for ipsilateral RSLNM. BioMed Central 2023-08-11 /pmc/articles/PMC10422770/ /pubmed/37568173 http://dx.doi.org/10.1186/s13014-023-02322-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Toya, Ryo
Matsuyama, Tomohiko
Saito, Tetsuo
Fukugawa, Yoshiyuki
Watakabe, Takahiro
Shiraishi, Shinya
Murakami, Daizo
Orita, Yorihisa
Hirai, Toshinori
Oya, Natsuo
Prevalence and risk factors for retropharyngeal and retro-styloid lymph node metastasis in hypopharyngeal carcinoma
title Prevalence and risk factors for retropharyngeal and retro-styloid lymph node metastasis in hypopharyngeal carcinoma
title_full Prevalence and risk factors for retropharyngeal and retro-styloid lymph node metastasis in hypopharyngeal carcinoma
title_fullStr Prevalence and risk factors for retropharyngeal and retro-styloid lymph node metastasis in hypopharyngeal carcinoma
title_full_unstemmed Prevalence and risk factors for retropharyngeal and retro-styloid lymph node metastasis in hypopharyngeal carcinoma
title_short Prevalence and risk factors for retropharyngeal and retro-styloid lymph node metastasis in hypopharyngeal carcinoma
title_sort prevalence and risk factors for retropharyngeal and retro-styloid lymph node metastasis in hypopharyngeal carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422770/
https://www.ncbi.nlm.nih.gov/pubmed/37568173
http://dx.doi.org/10.1186/s13014-023-02322-4
work_keys_str_mv AT toyaryo prevalenceandriskfactorsforretropharyngealandretrostyloidlymphnodemetastasisinhypopharyngealcarcinoma
AT matsuyamatomohiko prevalenceandriskfactorsforretropharyngealandretrostyloidlymphnodemetastasisinhypopharyngealcarcinoma
AT saitotetsuo prevalenceandriskfactorsforretropharyngealandretrostyloidlymphnodemetastasisinhypopharyngealcarcinoma
AT fukugawayoshiyuki prevalenceandriskfactorsforretropharyngealandretrostyloidlymphnodemetastasisinhypopharyngealcarcinoma
AT watakabetakahiro prevalenceandriskfactorsforretropharyngealandretrostyloidlymphnodemetastasisinhypopharyngealcarcinoma
AT shiraishishinya prevalenceandriskfactorsforretropharyngealandretrostyloidlymphnodemetastasisinhypopharyngealcarcinoma
AT murakamidaizo prevalenceandriskfactorsforretropharyngealandretrostyloidlymphnodemetastasisinhypopharyngealcarcinoma
AT oritayorihisa prevalenceandriskfactorsforretropharyngealandretrostyloidlymphnodemetastasisinhypopharyngealcarcinoma
AT hiraitoshinori prevalenceandriskfactorsforretropharyngealandretrostyloidlymphnodemetastasisinhypopharyngealcarcinoma
AT oyanatsuo prevalenceandriskfactorsforretropharyngealandretrostyloidlymphnodemetastasisinhypopharyngealcarcinoma